Merck appoints Bridgette Heller
pharmafile | March 5, 2010 | Appointment | Sales and Marketing | Merck, appointment, consumer healthcare, sales and marketing
Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care.
She moves to Merck from Johnson & Johnson, where she had served as president of that company’s global baby business since 2007.
Prior to that she was Johnson & Johnson’s global president, baby, kids and wound care.
In her new role Heller will leverage Merck’s consumer products brands to capitalise on new growth opportunities, including expanding the consumer business in markets outside the US.
Merck’s consumer products include nasal congestion spray Afrin, allergy treatment Claritin and Lotrimin for athletes foot.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Merck to acquire Curon Biopharmaceutical’s B-Cell Depletion Therapy
Merck have announced that they have entered into an agreement with private biotechnology company Curon …

Merck and Daiichi Sankyo expand development and commericalisation agreement to include MK-6070
Daiichi Sankyo and Merck (known as MSD outside of the US and Canada) have announced …






